Form Type: 4

SEC EDGAR Link
Accession Number:0000905148-20-000752
Date:2020-06-30
Issuer: APREA THERAPEUTICS, INC. (APRE)
Original Submission Date:

Reporting Person:

HENNEMAN JOHN B III
535 BOYLSTON STREET
BOSTON, MA 02116

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 38.78 2020-06-30 deemed execution date A 5,600 (a) 2030-06-30 common stock 5,600 $38.78 5,600 direct
Footnotes
IDfootnote
f1 the option vests in full on june 30, 2021 subject to the reporting person's continued service on the issuer's board of directors through and including the applicable vesting date and subject to acceleration under certain conditions.
WhaleWisdom Logo

Elevate your investments